| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $233.6M | -72.3% |
| Cost of Revenue | $119.6M | -70.1% |
| Gross Profit | $400.9M | -9.8% |
| R&D Expense | $203.7M | +4.5% |
| SG&A Expense | $51.1M | -4.9% |
| Operating Income | -$48.3M | +59.0% |
| Pre-tax Income | -$112.6M | +45.9% |
| Income Tax | -$14.5M | +53.1% |
| Net Income | -$98.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $67.1M | -35.4% |
| Accounts Receivable | $267.2M | -5.5% |
| Inventory | $75.4M | +39.6% |
| Current Assets | $478.0M | -0.6% |
| Total Assets | $1.26B | -6.8% |
| Current Liabilities | $330.5M | -4.1% |
| Long-term Debt | $306.3M | -12.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.4M | -237.4% |
| Capital Expenditures | $10.3M | -40.1% |
| Investing Cash Flow | -$12.1M | +14.5% |
| Financing Cash Flow | $931K | +102.8% |
| Free Cash Flow | -$36.6M | -1886.2% |
| +44.6% |
| EPS (Basic) | -$0.63 | +47.5% |
| EPS (Diluted) | -$0.63 | +47.5% |
| Total Liabilities |
| $737.1M |
| -10.2% |
| Stockholders' Equity | $518.4M | -1.7% |